Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
+3.34M
-
Total reported value, excl. options
-
$965M
-
Value change
-
+$188M
-
Number of buys
-
41
-
Number of sells
-
-34
-
Price
-
$50.84
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2021
84 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q1 2021.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
of 58.5M outstanding shares and own 32.46% of the company stock.
Largest 10 shareholders include FMR LLC (4.08M shares), Soleus Capital Management, L.P. (3.18M shares), Cormorant Asset Management, LP (2.19M shares), WELLINGTON MANAGEMENT GROUP LLP (1.51M shares), Farallon Capital Management, L.L.C. (1.49M shares), JANUS HENDERSON GROUP PLC (1.03M shares), VANGUARD GROUP INC (1M shares), BlackRock Inc. (967K shares), BAKER BROS. ADVISORS LP (825K shares), and BOXER CAPITAL, LLC (686K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.